{
  "retracted": false,
  "timestamp": 1586822400000,
  "updates": [
    {
      "timestamp": 1589391768314,
      "identifier": {
        "doi": "10.1038/s41591-020-0864-x"
      },
      "type": "correction"
    }
  ],
  "identifier": {
    "doi": "10.1038/s41591-019-0737-3"
  },
  "journal": "Nature Medicine",
  "publisher": "Springer Science and Business Media LLC",
  "title": "Author Correction: Safety and feasibility of anti-CD19 CAR T cells with fully human binding domains in patients with B-cell lymphoma"
}
